miR Scientific Is Transforming Cancer Management Into What It Should Be

miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management Platform®, a proprietary, non-invasive platform for the effective management of targeted diseases, initially focused on urological cancers. The platform is powered by the miR Sentinel® Prostate Cancer Test, a liquid biopsy urine test that can accurately detect, classify, and monitor prostate cancer based on the interrogation of small-non-coding RNAs extracted from urinary exosomes.

The miR Leadership Team

Sam Salman

Co-Founder, Chairman & CEO

Martin Tenniswood, Ph.D

Co-Founder and Chief Scientific Officer

Erik Johnson

Chief Operating Officer

Laurence Klotz, MD, FRCSC, CM

Chief Medical Officer

Tal Kimmel

Chief Strategy Officer

Jill Anderson, JD

Chief Legal Officer

Bob Flippin

Chief Administrative Officer

Ram Salman

Chief Information Officer

Eli Mor

General Manager, miR Scientific Israel

Gregory DiRienzo, Ph.D

Director of Biostatistics

Nathalie Bloch MD MPA

Head of Discovery Platform

Rob Tenniswood

Co-Founder, Executive Vice Chair

Amnon Katz, Ph.D

Head of Global Clinical Affairs

Wei-Lin “Winnie” Wang, Ph.D

Director of Clinical Research

John Dvor

Executive Vice President, Corporate Development

Austin Srejma

Vice President, Commercialization

Scot Nelson

Vice President, Head of Market Access

Avital Barlev

Vice President, Quality Assurance

Eytan Meisels, Ph.D

Vice President, Regulatory Affairs

Lesley E. Northrop, PhD, FACMG

Vice President, Operations

Arminda Figueroa

Chief of Staff, Country Manager, Puerto Rico

Stuart Kozlick

Senior Vice President, Canada

Avivit Raz

Executive Vice President, Business Development, Israel

Akira Tsukagawa

Head of miR Scientific Japan

Keren Nir

Vice President, Operations Israel


Sebastiano Cossia Castiglioni

Arun Kant

Deepak A. Kapoor, MD

Jim Roosevelt, JD

Alejandro Weinstein

Henry Weinstein

Scientific Advisory Board

Andrew Armstrong, MD

Sam Chang, MD MBA

Yuval Eshdat, Ph.D

Phillip C. Ginsberg, DO, JD

Kirsten Greene, MD

David Josephson, MD

Brianne Kent, PhD

James M. Libby, MD

James M. McKiernan, MD

Angel S. Muntaner Morales, MD

Chad Ritch, MD, MBA

Geoffrey Sonn, MD

Work At miR

Join a passionate, talented group of scientists, physicians, and business leaders to drive historic change in healthcare

miR Careers

miR Scientific is a majority-owned operating subsidiary of Impact NRS, headquartered in New York with operating subsidiaries in Canada and Israel.

Impact NRS is a leading innovation company developing transformative solutions to address persistent global challenges in human health, sustainable food production and agriculture. Their model incorporates breakthrough advances in science, statistics and computation to develop products and services for early and scalable adoption. Impact NRS collaborates with stakeholders worldwide to enable rapid commercialization of their ESG socially responsible initiatives.